Direct evidence for a polygenic etiology in familial multiple myeloma
- 7 April 2017
- journal article
- research article
- Published by American Society of Hematology in Blood Advances
- Vol. 1 (10), 619-623
- https://doi.org/10.1182/bloodadvances.2016003111
Abstract
Key Points Although common risk alleles for multiple myeloma have been identified, their contribution to familial MM is unknown. We demonstrate an enrichment of common MM risk alleles in familial cases, providing the first direct evidence for a polygenic contribution.This publication has 26 references indexed in Scilit:
- Family history of hematologic malignancies and risk of multiple myeloma: differences by race and clinical featuresCancer Causes & Control, 2015
- The UK10K project identifies rare variants in health and diseaseNature, 2015
- Genome-wide association analysis identifies 13 new risk loci for schizophreniaNature Genetics, 2013
- Inherited predisposition to multiple myelomaTherapeutic Advances in Hematology, 2013
- The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myelomaNature Genetics, 2013
- An integrated map of genetic variation from 1,092 human genomesNature, 2012
- Initial genome sequencing and analysis of multiple myelomaNature, 2011
- Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective studyBlood, 2009
- Familial Predisposition to Monoclonal Gammopathy of Unknown Significance, Waldenström's Macroglobulinemia, and Multiple MyelomaClinical Lymphoma Myeloma and Leukemia, 2009
- Familial risks and temporal incidence trends of multiple myelomaEuropean Journal Of Cancer, 2006